• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

功能性细胞活性的高通量评估揭示疾病机制并预测相关临床结果。

High throughput estimation of functional cell activities reveals disease mechanisms and predicts relevant clinical outcomes.

作者信息

Hidalgo Marta R, Cubuk Cankut, Amadoz Alicia, Salavert Francisco, Carbonell-Caballero José, Dopazo Joaquin

机构信息

Computational Genomics Department, Centro de Investigación Príncipe Felipe (CIPF), Valencia, 46012, Spain.

Functional Genomics Node (INB-ELIXIR-es), Valencia, 46012, Spain.

出版信息

Oncotarget. 2017 Jan 17;8(3):5160-5178. doi: 10.18632/oncotarget.14107.

DOI:10.18632/oncotarget.14107
PMID:28042959
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5354899/
Abstract

Understanding the aspects of the cell functionality that account for disease or drug action mechanisms is a main challenge for precision medicine. Here we propose a new method that models cell signaling using biological knowledge on signal transduction. The method recodes individual gene expression values (and/or gene mutations) into accurate measurements of changes in the activity of signaling circuits, which ultimately constitute high-throughput estimations of cell functionalities caused by gene activity within the pathway. Moreover, such estimations can be obtained either at cohort-level, in case/control comparisons, or personalized for individual patients. The accuracy of the method is demonstrated in an extensive analysis involving 5640 patients from 12 different cancer types. Circuit activity measurements not only have a high diagnostic value but also can be related to relevant disease outcomes such as survival, and can be used to assess therapeutic interventions.

摘要

理解导致疾病或药物作用机制的细胞功能方面是精准医学面临的主要挑战。在此,我们提出一种新方法,该方法利用信号转导的生物学知识对细胞信号传导进行建模。该方法将个体基因表达值(和/或基因突变)重新编码为信号传导回路活性变化的精确测量值,这些测量值最终构成了对通路内基因活性引起的细胞功能的高通量估计。此外,这种估计既可以在队列水平上进行,用于病例/对照比较,也可以针对个体患者进行个性化分析。该方法的准确性在一项涉及来自12种不同癌症类型的5640名患者的广泛分析中得到了证明。信号传导回路活性测量不仅具有很高的诊断价值,而且还可以与生存等相关疾病结局相关联,并可用于评估治疗干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8224/5354899/106de284f844/oncotarget-08-5160-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8224/5354899/5c722dd44c2a/oncotarget-08-5160-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8224/5354899/2f04242c24a5/oncotarget-08-5160-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8224/5354899/e7120d94789b/oncotarget-08-5160-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8224/5354899/ddd55ea88da4/oncotarget-08-5160-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8224/5354899/5513ec52cfc8/oncotarget-08-5160-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8224/5354899/106de284f844/oncotarget-08-5160-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8224/5354899/5c722dd44c2a/oncotarget-08-5160-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8224/5354899/2f04242c24a5/oncotarget-08-5160-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8224/5354899/e7120d94789b/oncotarget-08-5160-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8224/5354899/ddd55ea88da4/oncotarget-08-5160-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8224/5354899/5513ec52cfc8/oncotarget-08-5160-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8224/5354899/106de284f844/oncotarget-08-5160-g006.jpg

相似文献

1
High throughput estimation of functional cell activities reveals disease mechanisms and predicts relevant clinical outcomes.功能性细胞活性的高通量评估揭示疾病机制并预测相关临床结果。
Oncotarget. 2017 Jan 17;8(3):5160-5178. doi: 10.18632/oncotarget.14107.
2
RDF SKETCH MAPS - KNOWLEDGE COMPLEXITY REDUCTION FOR PRECISION MEDICINE ANALYTICS.RDF 草图地图——用于精准医学分析的知识复杂性降低
Pac Symp Biocomput. 2016;21:417-28.
3
Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.乙酰化和泛素化位点的频繁突变提示了癌症新的驱动机制。
Genome Med. 2016 May 12;8(1):55. doi: 10.1186/s13073-016-0311-2.
4
Identification of outcome-related driver mutations in cancer using conditional co-occurrence distributions.利用条件共现分布鉴定癌症中与结局相关的驱动突变。
Sci Rep. 2017 Feb 27;7:43350. doi: 10.1038/srep43350.
5
A computational method for clinically relevant cancer stratification and driver mutation module discovery using personal genomics profiles.一种利用个人基因组图谱进行临床相关癌症分层和驱动基因突变模块发现的计算方法。
BMC Genomics. 2015;16 Suppl 7(Suppl 7):S6. doi: 10.1186/1471-2164-16-S7-S6. Epub 2015 Jun 11.
6
RNA Bioinformatics for Precision Medicine.用于精准医学的RNA生物信息学
Adv Exp Med Biol. 2016;939:21-38. doi: 10.1007/978-981-10-1503-8_2.
7
The shortest path is not the one you know: application of biological network resources in precision oncology research.最短路径并非你所熟知的那条:生物网络资源在精准肿瘤学研究中的应用。
Mutagenesis. 2015 Mar;30(2):191-204. doi: 10.1093/mutage/geu078.
8
Integrating mutation and gene expression cross-sectional data to infer cancer progression.整合突变和基因表达横断面数据以推断癌症进展。
BMC Syst Biol. 2016 Jan 25;10:12. doi: 10.1186/s12918-016-0255-6.
9
Pathway Activation Analysis for Pan-Cancer Personalized Characterization Based on Riemannian Manifold.基于黎曼流形的泛癌个性化特征通路激活分析
Int J Mol Sci. 2024 Apr 17;25(8):4411. doi: 10.3390/ijms25084411.
10
Comparative analysis of protein interactome networks prioritizes candidate genes with cancer signatures.蛋白质相互作用组网络的比较分析对具有癌症特征的候选基因进行了优先排序。
Oncotarget. 2016 Nov 29;7(48):78841-78849. doi: 10.18632/oncotarget.12879.

引用本文的文献

1
RSEA: A Web Server for Pathway Enrichment Analysis of Metabolic Reaction Sets.RSEA:用于代谢反应集通路富集分析的网络服务器。
Biotechnol Bioeng. 2025 Aug;122(8):2251-2258. doi: 10.1002/bit.29020. Epub 2025 May 9.
2
CanSeer: a translational methodology for developing personalized cancer models and therapeutics.CanSeer:一种用于开发个性化癌症模型和疗法的转化方法。
Sci Rep. 2025 Apr 29;15(1):15080. doi: 10.1038/s41598-025-99219-x.
3
Strategy for drug repurposing in fibroadipogenic replacement during muscle wasting: application to duchenne muscular dystrophy.

本文引用的文献

1
Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients.作为生物标志物的信号通路模型:JNK活性的患者特异性模拟可预测神经母细胞瘤患者的生存率。
Sci Signal. 2015 Dec 22;8(408):ra130. doi: 10.1126/scisignal.aab0990.
2
Using activation status of signaling pathways as mechanism-based biomarkers to predict drug sensitivity.利用信号通路的激活状态作为基于机制的生物标志物来预测药物敏感性。
Sci Rep. 2015 Dec 18;5:18494. doi: 10.1038/srep18494.
3
The Molecular Taxonomy of Primary Prostate Cancer.
肌肉萎缩过程中纤维脂肪生成替代的药物重新利用策略:应用于杜氏肌营养不良症
Front Cell Dev Biol. 2025 Mar 26;13:1505697. doi: 10.3389/fcell.2025.1505697. eCollection 2025.
4
Pathway metrics accurately stratify T cells to their cells states.通路指标可准确地将T细胞分层至其细胞状态。
BioData Min. 2024 Dec 24;17(1):60. doi: 10.1186/s13040-024-00416-7.
5
Comparative profiling of whole-cell and exosome samples reveals protein signatures that stratify breast cancer subtypes.全细胞和外泌体样本的比较分析揭示了可分层乳腺癌亚型的蛋白质特征。
Cell Mol Life Sci. 2024 Aug 22;81(1):363. doi: 10.1007/s00018-024-05403-z.
6
Single cell RNA sequencing of human FAPs reveals different functional stages in Duchenne muscular dystrophy.人类脂肪成纤维细胞的单细胞RNA测序揭示了杜氏肌营养不良症的不同功能阶段。
Front Cell Dev Biol. 2024 Jul 9;12:1399319. doi: 10.3389/fcell.2024.1399319. eCollection 2024.
7
Interferon and B-cell Signatures Inform Precision Medicine in Lupus Nephritis.干扰素和B细胞特征为狼疮性肾炎的精准医学提供依据。
Kidney Int Rep. 2024 Mar 13;9(6):1817-1835. doi: 10.1016/j.ekir.2024.03.014. eCollection 2024 Jun.
8
NetActivity enhances transcriptional signals by combining gene expression into robust gene set activity scores through interpretable autoencoders.NetActivity 通过将基因表达组合成稳健的基因集活性评分,利用可解释的自动编码器增强转录信号。
Nucleic Acids Res. 2024 May 22;52(9):e44. doi: 10.1093/nar/gkae197.
9
drexml: A command line tool and Python package for drug repurposing.drexml:一种用于药物重新利用的命令行工具和Python包。
Comput Struct Biotechnol J. 2024 Mar 1;23:1129-1143. doi: 10.1016/j.csbj.2024.02.027. eCollection 2024 Dec.
10
Drug-target identification in COVID-19 disease mechanisms using computational systems biology approaches.利用计算系统生物学方法鉴定 COVID-19 疾病机制中的药物靶点。
Front Immunol. 2024 Feb 13;14:1282859. doi: 10.3389/fimmu.2023.1282859. eCollection 2023.
原发性前列腺癌的分子分类学
Cell. 2015 Nov 5;163(4):1011-25. doi: 10.1016/j.cell.2015.10.025.
4
Temporal Identification of Dysregulated Genes and Pathways in Clear Cell Renal Cell Carcinoma Based on Systematic Tracking of Disrupted Modules.基于对失调模块的系统追踪对透明细胞肾细胞癌中失调基因和通路的时间识别
Comput Math Methods Med. 2015;2015:313740. doi: 10.1155/2015/313740. Epub 2015 Oct 12.
5
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.乳头状肾细胞癌的综合分子特征分析
N Engl J Med. 2016 Jan 14;374(2):135-45. doi: 10.1056/NEJMoa1505917. Epub 2015 Nov 4.
6
ToPASeq: an R package for topology-based pathway analysis of microarray and RNA-Seq data.ToPASeq:一个用于基于拓扑结构的微阵列和RNA测序数据通路分析的R包。
BMC Bioinformatics. 2015 Oct 29;16:350. doi: 10.1186/s12859-015-0763-1.
7
Gluconeogenesis combats cancer: opening new doors in cancer biology.糖异生对抗癌症:开启癌症生物学的新大门。
Cell Death Dis. 2015 Sep 3;6(9):e1872. doi: 10.1038/cddis.2015.245.
8
Subpathway Analysis based on Signaling-Pathway Impact Analysis of Signaling Pathway.基于信号通路的信号通路影响分析的子通路分析
PLoS One. 2015 Jul 24;10(7):e0132813. doi: 10.1371/journal.pone.0132813. eCollection 2015.
9
Empirical comparison of structure-based pathway methods.基于结构的通路方法的实证比较。
Brief Bioinform. 2016 Mar;17(2):336-45. doi: 10.1093/bib/bbv049. Epub 2015 Jul 21.
10
Integrating Microarray Data and GRNs.整合微阵列数据与基因调控网络
Methods Mol Biol. 2016;1375:137-53. doi: 10.1007/7651_2015_252.